Arhaus, Inc. Class A ARHS 深 沪
等待开盘 06-30 09:30:00 美东时间
8.42
+0.010
+0.12%
华盛通- 最 高8.635
- 今 开8.30
- 成交量 187.30万股
- 最 低 8.29
- 昨 收 8.41
- 总市值 11.92亿
- 52周最高 12.63
- 市盈率 静 17.70
- 换手率 1.32%
- 52周最低 5.57
- 委 比 -84.19%
- 总股本 1.42亿
- 历史最高 19.46
- 量 比 1.33
- 振 幅 4.10%
- 历史最低 3.38
- 每 手 1
- 风险率 1.72%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Arhaus涨势遇阻 技术指标发出警示信号
阿豪斯（股票代码ARHS.O）近期累计涨幅达16.87%，当前呈现基本面扎实、资金面正向但技术面偏弱、零售宏观环境偏谨慎的分化格局。 关键核心数据如下： 5名...
06-26 10:55
Housing market data gives furnishing, home improvement stocks a lift
Home furnishing and home improvement stocks are getting a boost on Thursday thanks to better-than-expected May housing data. Existing home sales rose 3.2% last month to a seasonally adjusted annual ra...
06-09 23:22
Arhaus Announces Participation in Jefferies Consumer Conference in Nantucket
Arhaus, a premium home furnishing brand, announced its participation in the Jefferies Consumer Conference in Nantucket, Massachusetts on June 16–17, 2026. CFO Michael Lee and Vice President, Head of Investor Relations Tara Atwood-Saja will attend investor meetings. Founded in 1986, Arhaus offers responsibly sourced, artisan-crafted furniture and décor through an integrated omni-channel model, with over 100 Showroom locations nationwide.
06-02 20:01
美股大行评级 | Arxis、Madison Air获多家大行首予买入评价！潜在涨幅441.87%！Caribou Biosciences获HC Wainwright & Co.升目标价至11美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Caribou Biosciences"买入"评级，目标价从9美元升至11美元；康托·菲茨杰拉德：维持Artiva Biotherapeutics"超配"评级，目标价从10美元升至40美元
05-12 12:36
美股大行评级 | 爱彼迎、Affirm、CoreWeave、Datadog、微芯科技等获多家大行上调目标价；HubSpot惨遭14家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持Artiva Biotherapeutics"买入"评级，目标价从15美元升至35美元；韦德布什：维持Cullinan Therapeutics"跑赢大市"评级，目标价从36美元升至37美元
05-11 15:43
Arhaus Affirms FY2026 Sales Guidance of $1.430B-$1.470B vs $1.448B Est
Arhaus (NASDAQ:ARHS) affirms FY2026 sales outlook from $1.430 billion-$1.470 billion to $1.430 billion-$1.470 billion vs $1.448 billion estimate.
05-07 18:06
Arhaus Sees Q2 Sales $350.000M-$370.000M vs $369.105M Est
Arhaus (NASDAQ:ARHS) sees Q2 sales of $350.000 million-$370.000 million vs $369.105 million analyst estimate.
05-07 18:05
Arhaus Q1 EPS $0.02, Inline, Sales $314.276M Beat $313.941M Estimate
Arhaus (NASDAQ:ARHS) reported quarterly earnings of $0.02 per share which met the analyst consensus estimate. This is a 33.33 percent decrease over earnings of $0.03 per share from the same period last year. The company
05-07 18:04
美股大行评级 | 潜在涨幅85%！SoFi获机构升目标价至49美元；华尔街大行看涨AMD至400美元
今日重点评级关注：Canaccord Genuity：维持Sagimet Biosciences"买入"评级，目标价从28美元升至49美元；HC Wainwright & Co.：维持Fate Therapeutics"买入"评级，目标价从5美元升至7美元
05-05 11:40
Telsey Advisory Group Maintains Market Perform on Arhaus, Lowers Price Target to $9
Telsey Advisory Group analyst Cristina Fernandez maintains Arhaus (NASDAQ:ARHS) with a Market Perform and lowers the price target from $11 to $9.
05-05 03:29
